Skip to main content

Table 5 Analysis of the difference of NLR between tumor-free people and ESCC patients

From: Post treatment NLR is a predictor of response to immune checkpoint inhibitor therapy in patients with esophageal squamous cell carcinoma

Group

NLR level

 < 3.23

 ≥ 3.23

Total

ESCC patients

60

59

119

Tumor-free people

795

14

818

Total

855

73

937

P value

 < 0.05

  
Back to article page

Cancer Cell International

ISSN: 1475-2867

Contact us